AARTI DRUGS
Back to Balance Sheet
|
AARTI DRUGS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹282 Cr | ₹249 Cr | ₹194 Cr | ₹185 Cr | ₹151 Cr |
What is the latest Contingent Liabilities ratio of AARTI DRUGS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹282 Cr |
| Mar2024 | ₹249 Cr |
| Mar2023 | ₹194 Cr |
| Mar2022 | ₹185 Cr |
| Mar2021 | ₹151 Cr |
How is Contingent Liabilities of AARTI DRUGS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹282 Cr | 13.34 | |
| Mar2024 | ₹249 Cr | 28.21 | |
| Mar2023 | ₹194 Cr | 4.83 | |
| Mar2022 | ₹185 Cr | 22.44 | |
| Mar2021 | ₹151 Cr | - | |
Compare Contingent Liabilities of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,569.4 Cr | 2.8% | 12.6% | 12.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,859.0 Cr | 4.2% | 5.3% | 1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,618.0 Cr | 3.4% | 12.6% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,718.0 Cr | 2.2% | 4.1% | 28% | Stock Analytics | |
| CIPLA | ₹107,722.0 Cr | 2% | 11.5% | -13.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,081.0 Cr | -6.2% | 5.1% | 9.5% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | 2.8% |
12.6% |
12.4% |
| SENSEX | -0.4% |
7.1% |
-4% |
You may also like the below Video Courses